{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:36:42Z","timestamp":1747208202256,"version":"3.40.5"},"reference-count":40,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.2217\/imt-2021-0030","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T09:54:10Z","timestamp":1624960450000},"page":"1105-1111","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Checkpoint Inhibitors in BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Can they Help Spare the Bladder?"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2006-8232","authenticated-orcid":false,"given":"Khalil","family":"El Gharib","sequence":"first","affiliation":[{"name":"Department of Hematology-Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5050-5232","authenticated-orcid":false,"given":"Eddy","family":"Lilly","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Chebel","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"1","key":"e_1_3_2_3_1","first-page":"15","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala K","year":"2020","unstructured":"Saginala K , BarsoukA , AluruJS , RawlaP , PadalaSA , BarsoukA. Epidemiology of bladder cancer. Med. Sci. (Basel)8(1), 15 (2020).","journal-title":"Med. Sci. (Basel)"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1210"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2020.1822743"},{"issue":"6","key":"e_1_3_2_6_1","first-page":"S199","article-title":"The management of BCG failure in non-muscle-invasive bladder cancer: an update","volume":"3","author":"Zlotta AR","year":"2009","unstructured":"Zlotta AR , FleshnerNE , JewettMA. The management of BCG failure in non-muscle-invasive bladder cancer: an update. Can. Urol. Assoc. J.3(6 Suppl. 4), S199\u2013S205 (2009).","journal-title":"Can. Urol. Assoc. J."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000769"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000297"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.6101"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03474-8"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2019.03.006"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835918788310"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2019.09.012"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.12.020"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5041"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000789"},{"key":"e_1_3_2_17_1","unstructured":"Merck Sharp & Dohme\n. NCT03711032 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03711032"},{"key":"e_1_3_2_18_1","unstructured":"ClinicalTrials.gov\n. NCT02324582 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02324582"},{"key":"e_1_3_2_19_1","unstructured":"ClinicalTrials.gov\n. NCT04164082 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT04164082"},{"key":"e_1_3_2_20_1","unstructured":"ClinicalTrials.gov\n. NCT02621151 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02621151"},{"key":"e_1_3_2_21_1","unstructured":"ClinicalTrials.gov\n. NCT02662062 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02662062"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.406"},{"key":"e_1_3_2_23_1","unstructured":".Bristol-Myers Squibb. NCT04149574 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04149574"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3181eb3343"},{"issue":"15","key":"e_1_3_2_25_1","article-title":"A Phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette\u2013Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle invasive bladder cancer (NMIBC): checkMate 9UT","volume":"38","author":"Hahn","year":"2020","unstructured":"Hahn . A Phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette\u2013Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle invasive bladder cancer (NMIBC): checkMate 9UT. J. Clin. Oncol.38(Suppl. 15), (2020).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_2_26_1","unstructured":"ClinicalTrials.gov\n. NCT03519256 (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03519256"},{"key":"e_1_3_2_27_1","unstructured":"National Cancer Institute\n . NCT02844816 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02844816"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5022"},{"key":"e_1_3_2_29_1","unstructured":"ClinicalTrials.gov\n. NCT02792192 (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02792192"},{"key":"e_1_3_2_30_1","unstructured":"UNICANCER\n. NCT03799835 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03799835"},{"key":"e_1_3_2_31_1","unstructured":"H. Lee Moffitt Cancer Center and Research Institute\n. NCT02901548 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02901548"},{"key":"e_1_3_2_32_1","unstructured":"ClinicalTrials.gov\n. NCT03317158 (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03317158"},{"key":"e_1_3_2_33_1","unstructured":"ClinicalTrials.gov\n. NCT03528694 (2021). https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03528694"},{"key":"e_1_3_2_34_1","unstructured":"Hellenic GenitoUrinary Cancer Group\n. NCT03759496 (2020). https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03759496"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-020-01666-1"},{"key":"e_1_3_2_36_1","unstructured":"Institut Paoli-Calmettes\n. NCT03950362 (2019). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03950362"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.06.009"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01148"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.10.026"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.4506"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1655730"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000533"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2021-0030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:22:08Z","timestamp":1715970128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2021-0030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.2217\/imt-2021-0030"],"URL":"https:\/\/doi.org\/10.2217\/imt-2021-0030","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"type":"print","value":"1750-743X"},{"type":"electronic","value":"1750-7448"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}